Research and Markets: Dermatitis - Pipeline Review, H2 2012
Research and Markets (http://www.researchandmarkets.com/research/dbcbh9/dermatitis) has announced the addition of the "Dermatitis - Pipeline Review, H2 2012" report to their offering.
This research provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Dermatitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dermatitis.
The data is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
- A snapshot of the global therapeutic scenario for Dermatitis.
- A review of the Dermatitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Dermatitis pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered:
List of Tables
List of Figures
An Overview of Pipeline Products for Dermatitis
Dermatitis Therapeutics under Development by Companies
Dermatitis Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Mid Clinical Stage Products
Early Clinical Stage Products
Discovery and Pre-Clinical Stage Products
Dermatitis Therapeutics - Products under Development by Companies
Dermatitis Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Dermatitis Therapeutics Development
Dermatitis Therapeutics - Drug Profile Updates
Dermatitis Therapeutics - Discontinued Products
Dermatitis Therapeutics - Dormant Products
Dermatitis - Product Development Milestones
Featured News & Press Releases
Companies Mentioned: (58)
- Almirall, S.A
- Amgen Inc
- AnGes MG
- Array BioPharma Inc
- Bayer HealthCare AG
- Bristol-Myers Squibb Company
- Daiichi Sankyo Company
- Eisai Co
- Galderma S.A
- Hanall Pharmaceutical Co
- LEO Pharma A/S
- MedImmune LLC
- NicOx SA
- Nippon Shinyaku Co
- Novartis AG
- Nuvo Research Inc
- ProMetic Life Sciences Inc
- Provectus Pharmaceuticals
- Proximagen Neuroscience
- R-Tech Ueno
- Regeneron Pharmaceuticals, Inc
- Stiefel Laboratories
- Summit Corporation
For more information visit http://www.researchandmarkets.com/research/dbcbh9/dermatitis